Affiliation: University of Pennsylvania
- Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference caseHoa H Le
Pharmacoepidemiology and Pharmacoeconomics, University of Groningen, Antonius Deusinglaan 1, 9713, Groningen, The Netherlands
Eur Child Adolesc Psychiatry 23:587-98. 2014..The limited number of European-based studies examining the economic burden of ADHD highlights the need for more research in this area...
- Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured populationJalpa A Doshi
University of Pennsylvania, 1222 Blockley Hall, Philadelphia, PA 19104, USA
J Manag Care Spec Pharm 20:382-90. 2014..The prevalence of irritable bowel syndrome with constipation (IBS-C) is estimated to be between 4.3% and 5.2% among adults in the United States. Little is known about the health care resource utilization and costs associated with IBS-C...
- Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United StatesJalpa A Doshi
Perelman School of Medicine, University of Pennsylvania, USA
J Am Acad Child Adolesc Psychiatry 51:990-1002.e2. 2012..This article comprehensively reviews studies reporting ADHD-related incremental (excess) costs for children/adolescents and adults and presents estimates of annual national incremental costs of ADHD...
- Comparison of the performance of the CMS Hierarchical Condition Category (CMS-HCC) risk adjuster with the Charlson and Elixhauser comorbidity measures in predicting mortalityPengxiang Li
Division of General Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
BMC Health Serv Res 10:245. 2010..This study intends to assess the performance of the CMS-HCC risk adjustment method and to compare it to the Charlson and Elixhauser comorbidity measures in predicting in-hospital and six-month mortality in Medicare beneficiaries...
- Impact of the Medicare Modernization Act of 2003 on utilization and spending for medicare part B-covered biologics in rheumatoid arthritisJalpa A Doshi
University of Pennsylvania School of Medicine and Leonard Davis Institute of Health Economics, Philadelphia, PA 19104 6021, USA
Arthritis Care Res (Hoboken) 62:354-61. 2010....
- Drug benefit generosity and essential medication use among Medicare-eligible retireesJalpa A Doshi
Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104 6021, USA
Am J Manag Care 13:425-31. 2007..To examine the association between generosity of drug coverage and essential cardiovascular medication use among retired seniors...
- Prevalence and trends in obesity among aged and disabled U.S. Medicare beneficiaries, 1997-2002Jalpa A Doshi
University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Health Aff (Millwood) 26:1111-7. 2007..4 percent and 32.5 percent, respectively, in 1997. Using 2002 data, we estimate that three million beneficiaries would be eligible for bariatric surgery coverage under current Medicare policy...
- Impact of a prescription copayment increase on lipid-lowering medication adherence in veteransJalpa A Doshi
Center for Health Research and Promotion, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA
Circulation 119:390-7. 2009..We examined the impact of the copayment increase on lipid-lowering medication adherence...
- National estimates of medication use in nursing homes: findings from the 1997 medicare current beneficiary survey and the 1996 medical expenditure surveyJalpa A Doshi
School of Medicine, Universityof Pennsylvania, Philadelphia, Pennsylvania, USA
J Am Geriatr Soc 53:438-43. 2005..To provide the first nationwide estimates of medication use in nursing homes (NHs) and to introduce a new data set for examining drug use in long-term care facilities...
- The impact of drug coverage on COX-2 inhibitor use in MedicareJalpa A Doshi
Division of General Internal Medicine, University of Pennsylvania, Philadelphia, USA
Health Aff (Millwood) . 2004..However, this risk differential in COX-2 use disappears among those with the most generous coverage. Potential overuse of costly medications should be addressed as the Medicare drug benefit is being phased in...
- Analyses of cost data in economic evaluations conducted alongside randomized controlled trialsJalpa A Doshi
Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA
Value Health 9:334-40. 2006..The objective of this article is to evaluate the statistical methods used for analysis of cost data in economic evaluations conducted alongside randomized controlled trials...
- The shape of things to come: obesity, aging, and disabilityDawn E Alley
Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA
LDI Issue Brief 13:1-4. 2008..This issue Brief summarizes two studies that examine the prevalence of obesity over time in the elderly and disabled, and the changing relationship of obesity and disability...
- Clinical trial-based cost-effectiveness analyses of antipsychotic useDaniel Polsky
Division of General Internal Medicine, University of Pennsylvania, Philadelphia, USA
Am J Psychiatry 163:2047-56. 2006..Given limited health care resources, assessment of the value for the cost of second-generation antipsychotics relative to first-generation antipsychotics is critical for resource-allocation decisions...
- The health effects of Medicare for the near-elderly uninsuredDaniel Polsky
Division of General Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
Health Serv Res 44:926-45. 2009..To determine whether Medicare enrollment at age 65 has an effect on the health trajectory of the near-elderly uninsured...
- Long-term risk for depressive symptoms after a medical diagnosisDaniel Polsky
Division of General Internal Medicine, University of Pennsylvania Medical Center, Philadelphia, USA
Arch Intern Med 165:1260-6. 2005..This study examines the risk of development of significant depressive symptoms after a new diagnosis of cancer, diabetes, hypertension, heart disease, arthritis, chronic lung disease, or stroke...
- Psychotropic medication use among Medicaid-enrolled children with autism spectrum disordersDavid S Mandell
University of Pennsylvania School of Medicine, Department of Psychiatry, Philadelphia, PA 19104, USA
Pediatrics 121:e441-8. 2008....
- Depression and retirement in late middle-aged U.S. workersJalpa A Doshi
University of Pennsylvania, Blockley Hall, Rm 1222, 423 Guardian Drive, Philadelphia, PA 19104 6021, USA
Health Serv Res 43:693-713. 2008..To determine whether late middle-aged U.S. workers with depression are at an increased risk for retirement...
- Comparative effectiveness and cost-effectiveness analyses frequently agree on valueHenry A Glick
Henry A Glick is a professor of medicine in the Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, in Philadelphia
Health Aff (Millwood) 34:805-11. 2015..Disagreement is more likely to occur if a treatment intervention is musculoskeletal and less likely to occur if it is surgical or involves secondary prevention, or if the study was funded by a pharmaceutical company. ..
- A test of financial incentives to improve warfarin adherenceKevin G Volpp
Center for Health Equity Research and Promotion, Philadelphia Veterans Affairs Medical Center, Philadelphia, PA, USA
BMC Health Serv Res 8:272. 2008..Novel methods are needed to improve adherence for warfarin. We conducted two pilot studies to determine whether a lottery-based daily financial incentive is feasible and improves warfarin adherence and anticoagulation control...
- Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetesBruce Stuart
Pharmaceutical Health Services Research Department, The Peter Lamy Center on Drug Therapy and Aging, University of Maryland School of Pharmacy, Baltimore, MD, USA
Med Care 50:913-9. 2012..It is not known whether low-income subsidies (LIS) under Medicare Part D help beneficiaries overcome impediments to medication use associated with poor socioeconomic status and high disease burden...
- Predictability of prescription drug expenditures for Medicare beneficiariesMarian V Wrobel
University of Pennsylvania School of Medicine, USA
Health Care Financ Rev 25:37-46. 2003..Adding lagged drug expenditures more than doubled predictive power to 55 percent. These results are discussed in the context of forecasting, and risk adjustment for the proposed new Medicare drug benefit...
- The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force ReportWilliam F McGhan
University of the Sciences, 600 South 43rd Street, Philadelphia, PA, USA
Value Health 12:1086-99. 2009..They were drawn from industry, academia, consulting organizations, and advisors to governments and came from Japan, the Netherlands, Canada and the United States...
- Second-generation antipsychotics: cost-effectiveness, policy options, and political decision makingRobert A Rosenheck
Department of Psychiatry, Yale Medical School, New Haven, CT 06516, USA
Psychiatr Serv 59:515-20. 2008..High expenditures on these medications are thus likely to continue without concomitant gains for public health...
- Impact of prescription coverage on hospital and physician costs: a case study of medicare beneficiaries with chronic obstructive pulmonary diseaseBruce Stuart
Peter Lamy Center on Drug Therapy and Aging, University of Maryland School of Pharmacy, 515 W Lombard Street, Room 157, Baltimore, MD 21201, USA
Clin Ther 26:1688-99. 2004..Any possible impact would be most apparent in patients with medication-sensitive disease conditions, such as chronic obstructive pulmonary disease (COPD)...
- The quality of antipsychotic drug prescribing in nursing homesBecky A Briesacher
Division of Geriatric Medicine, University of Massachusetts Medical School, Worcester 01605, USA
Arch Intern Med 165:1280-5. 2005....
- Medicare beneficiaries and the impact of gaining prescription drug coverage on inpatient and physician spendingBecky A Briesacher
Division of Geriatric Medicine, University of Massachusetts Medical School, Worchester, MA 01605, USA
Health Serv Res 40:1279-96. 2005..To assess whether gaining prescription drug coverage produces cost offsets in Medicare spending on inpatient and physician services...
- Propoxyphene use by community-dwelling and institutionalized elderly Medicare beneficiariesSachin J Kamal-Bahl
University of Maryland Baltimore, School of Pharmacy, Maryland 21201, USA
J Am Geriatr Soc 51:1099-104. 2003....
- Differential loss to follow-up by insurance status in the Health and Retirement Study: implications for national estimates on health insurance coverageDaniel Polsky
Arch Intern Med 165:2537-8; author reply 2538. 2005
- Policy implications of CATIERobert A Rosenheck
Psychiatr Serv 59:695. 2008
- Antihypertensive use and adherence and blood pressure stress response among black caregivers and non-caregiversJalpa A Doshi
University of Maryland, School of Pharmacy, Baltimore, MD 21201, USA
Appl Nurs Res 16:266-77. 2003..These findings contradict previous findings among white caregivers and non-caregivers and suggest different practice implications...
- Life Cycle Effects of Health Insurance on Elderly HealthJalpa Doshi; Fiscal Year: 2006..We will use these estimates to simulate the effect of changes in the age of Medicare eligibility on health, medical service use and Medicare expenditure. ..
- Impact of Medicaid Prescription Copayments in Patients with SchizophreniaJalpa Doshi; Fiscal Year: 2009..The findings of our study will help inform policymakers about the intended and unintended consequences of prescription copayments in Medicaid patients with schizophrenia. ..